Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection

NCT05443412 · Chinese University of Hong Kong · Updated 20 May 2025

What is being tested
Diagnostic test for prostate cancer
For
Prostate Cancer
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 510 people. The full rules are on the registry page.
Where
Hong Kong
When
Starts or started 1 Aug 2023, ends 30 Oct 2026. Registered 5 July 2022.
Results
None posted yet.

In the researchers' words

This is a prospective clinical study recruiting 510 men at risk of PCa to undergo urine, blood, AI-assisted ultrasound and AI-assisted MRI investigations to stratify risk of clinically significant PCa (csPCa). (sample size calculation in section 5)
ClinicalTrials.gov, NCT05443412

Sites

  • Prince of Wales Hospital, Chinese University of Hong KongHong Kong, Hong Kong